These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 17661414

  • 1. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

  • 2. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [Abstract] [Full Text] [Related]

  • 3. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
    Adams LA, Feldstein AE.
    J Dig Dis; 2011 Feb; 12(1):10-6. PubMed ID: 21091933
    [Abstract] [Full Text] [Related]

  • 4. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive assessment of fibrosis and steatosis in NASH and ASH.
    Angulo P.
    Gastroenterol Clin Biol; 2009 Apr; 33(10-11):940-8. PubMed ID: 19800187
    [Abstract] [Full Text] [Related]

  • 6. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 7. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

  • 8. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 9. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.
    Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE.
    Hepatology; 2006 Jul; 44(1):27-33. PubMed ID: 16799979
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.
    Wieckowska A, Feldstein AE.
    Semin Liver Dis; 2008 Nov; 28(4):386-95. PubMed ID: 18956295
    [Abstract] [Full Text] [Related]

  • 11. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Nov; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA, Hadziyannis SJ.
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [Abstract] [Full Text] [Related]

  • 13. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.
    Palekar NA, Naus R, Larson SP, Ward J, Harrison SA.
    Liver Int; 2006 Mar; 26(2):151-6. PubMed ID: 16448452
    [Abstract] [Full Text] [Related]

  • 14. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C, Younossi ZM.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L, Forgione A, Gasbarrini G, Grieco A.
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [Abstract] [Full Text] [Related]

  • 16. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ.
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [Abstract] [Full Text] [Related]

  • 17. Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: a promising approach.
    Valenti L, Dongiovanni P.
    Transl Res; 2010 Oct; 156(4):226-8. PubMed ID: 20875898
    [Abstract] [Full Text] [Related]

  • 18. [Imaging of NASH].
    Tanimoto A, Tomita K.
    Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120
    [Abstract] [Full Text] [Related]

  • 19. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.
    Vizzutti F, Arena U, Nobili V, Tarquini R, Trappoliere M, Laffi G, Marra F, Pinzani M.
    Ann Hepatol; 2009 Jun; 8(2):89-94. PubMed ID: 19502649
    [Abstract] [Full Text] [Related]

  • 20. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD.
    Prostaglandins Leukot Essent Fatty Acids; 2010 Jun; 82(4-6):265-71. PubMed ID: 20189787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.